SNS-103
sensei biotherapeutics
['$snse', 'sensei']
$snse sensei biotherapeutics presents new preclinical data on sns-103 targeting entpdase1 (cd39) at the american association for cancer research (aacr) annual meeting 2023 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities